PPHC Public Reporting

ACO Name & Location

Premier Patient Healthcare, LLC

2340 East Trinity Mills

Carrollton, TX 75006

ACO Primary Contact

Michelle Storto

info@premiermgmtco.com

Phone:702-824-0735

Organizational Information:

ACO Participants:

ACO Participants

ACO Participant in Joint Venture

ADEL A ZAKHARY PA

N

ADVANCED FAMILY MEDICAL CARE PA

N

AGNES KINRA MD, PA

N

ALLEN FRIENDS & FAMILY CLINIC PLLC

N

ALOK KUSHWAHA MD PA

N

ANJANI AMIN, MD PA

N

ANN H SNYDER MD P.A.

N

BHARMAL INTERNAL MEDICINE ASSOCIATES,P.A.

N

BILL BURKE A PROFESSIONAL ASSOCIATION

N

BIORHYTHMS MEDICAL PRACTICE

N

BROOKS TROTTER

N

CAPILI PA

N

CENTENNIAL PRIMARY CARE PLLC

N

DAVID N PODGURECKI, MD PA

N

DONALD WHITCOMB

N

DR. TANVIR AHMAD AND DR. FAUZIA KHALIDA OSAMA M.D. PA

N

FRELYN LOUGHRIDGE FAMILY NURSE PRACTITIONER PC

N

HAMID BURNEY, M.D., P.A.

N

JAISWAL CLINIC PLLC

N

JALIL KHAN, MD, PA

N

JIAUL AHSAN PLLC

N

JOHN FERRIS

N

KEITH WILKERSON

N

KEVIN J KALLAL MD PA

N

LIFES CYCLE WOMENS CARE PC

N

LOUIS A TORRES JR MD. PLLC

N

MARK E GIBBS MD. & ASSOCIATES LLC

N

MARK L GINNINGS PA

N

MARK R. KLEIN, D.O. & ASSOCIATES, PLLC

N

MARTYN GORDON

N

MCKINNEY ADULT MEDICINE, PA

N

MICHELLE ABBE HACKER PLLC

N

NORTH COUNTRY FAMILY PRACTICE, PA

N

PAMELA MOORE, MD, PA

N

PRESTON MEDICAL ASSOCIATES PA

N

ROBERT R. MCLEROY, M.D. & ASSOCIATES A PROFESSIONAL LLC

N

SONG LEE

N

SOUTHERN MEDICAL ASSOCIATES PLLC

N

SOUTHWARD FAMILY MEDICINE

N

STEVE WATKINS DO PC

N

TEXAS FAMILICARE MEDICAL GROUP PLLC

N

THOMAS J MILLER PA

N

TIMARRON FAMILY MEDICINE PA

N

TRUESMEDICINE PA

N
ACO governing body

Member

Last Name

Member

First Name

Member

Title/Position

 Member’s Voting Power (Expressed as a percentage or number) Membership Type ACO Participant Legal Business Name and D/B/A, if applicable
Ahmad Tanvir M.D., Medical Director, Voting Member 14.3% ACO Participant Representative Dr. Tanvir Ahmad and Dr. Fauzia Khalida Osama M.D. PA
Jaiswal Deepak M.D., Chairman, Voting Member 14.3% ACO Participant Representative Jaiswal Clinic PLLC
Parisi Michael D.O., Vice Chairman, Voting Member 14.3% ACO Participant Representative McKinney Adult Medicine, PA
Ginnings Mark M.D., Voting Member 14.3% ACO Participant Representative Mark L Ginnings PA
Lee Song M.D., Voting Member 14.3% ACO Participant Representative Song Lee
Wilkerson Keith M.D., Voting Member 14.3% ACO Participant Representative Keith Wilkerson
Coletta Cindy Voting Member 7.1% Medicare Beneficiary Representative N/A
Kazi Mohammad Voting Member 7.1% Other/ACO Management Representative Premier Management Company

 

Key ACO clinical and administrative leadership

ACO Executive: Mohammad Kazi

Medical Director: Tanvir Ahmad, MD

Compliance Officer: Tiffany Marcks

Quality Assurance/Improvement Officer: Kathy Johnson

Associated committees and committee leadership

Regional board members serve as the region’s committee for quality, utilization, engagement, finance and compliance.

 

Committee Name Committee Leader Name and Position

Arlington Regional Board

Grapevine Regional Board

 

 

Hamid Burney, MD, Chair

Chris King, MD, Chair

 

 
Types of ACO participants, or combinations of participants, that formed the ACO
  • Network of individual practices of ACO professionals

Shared Savings and Losses:

Amount of Shared Savings/Losses
  • Third Agreement Period
    • Performance Year 2020, $4,298,247
  • Second Agreement Period
    • Performance Year 2019, $4,472,389
    • Performance Year 2018, $1,523,320
    • Performance Year 2017, $2,215,242
  • First Agreement Period
    • Performance Year 2016, $12,568,102
    • Performance Year 2015, $5,835,335
    • Performance Year 2014, $5,806,261

Shared Savings Distribution:

  • Third Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 51%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 45%
    • Second Agreement Period
      • Performance Year 2019
        • Proportion invested in infrastructure: 55%
        • Proportion invested in redesigned care processes/resources: 0%
        • Proportion of distribution to ACO participants: 49%
      • Performance Year 2018
        • Proportion invested in infrastructure: 47%
        • Proportion invested in redesigned care processes/resources: 13%
        • Proportion of distribution to ACO participants: 40%
      • Performance Year 2017
        • Proportion invested in infrastructure: 27%
        • Proportion invested in redesigned care processes/resources: 0%
        • Proportion of distribution to ACO participants: 73%
      • First Agreement Period
        • Performance Year 2016
          • Proportion invested in infrastructure: 25%
          • Proportion invested in redesigned care processes/resources: 0%
          • Proportion of distribution to ACO participants: 75%
        • Performance Year 2015
          • Proportion invested in infrastructure: 25%
          • Proportion invested in redesigned care processes/resources: 0%
          • Proportion of distribution to ACO participants: 75%
        • Performance Year 2014
          • Proportion invested in infrastructure: 25%
          • Proportion invested in redesigned care processes/resources: 0%
          • Proportion of distribution to ACO participants: 75%

Quality Performance Results

2020 Quality Performance Results:

ACO Quality Measure Number Measure Name Rate ACO Mean
ACO43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI) #91) 0.75 0.95
ACO13 Falls:  Screening for Future Fall Risk 83.18 84.97
ACO14 Preventive Care and Screening:  Influenza  Immunization 80.21 76.03
ACO17 Preventive Care and Screening:  Tobacco Use:  Screening and Cessation Intervention 83.33 81.67
ACO18 Preventive Care and Screening for Clinical Depression and Follow-up Plan 55.51 71.46
ACO19 Colorectal Cancer Screening 70.20 72.59
ACO20 Breast Cancer Screening 66.28 74.05
ACO42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 75.30 83.37
ACO27 Diabetes:  Hemoglobin A1c Poor Control 11.11 14.70
ACO28 Controlling High Blood Pressure 79.78 72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov